Compare RDNT & GNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDNT | GNTX |
|---|---|---|
| Founded | 1985 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.0B |
| IPO Year | 1996 | 1995 |
| Metric | RDNT | GNTX |
|---|---|---|
| Price | $76.05 | $22.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $82.80 | $26.60 |
| AVG Volume (30 Days) | 632.3K | ★ 2.2M |
| Earning Date | 05-11-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 2.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | $1,616,630,000.00 | ★ $2,534,268,965.00 |
| Revenue This Year | $22.78 | $6.89 |
| Revenue Next Year | $10.70 | $4.58 |
| P/E Ratio | ★ N/A | $22.46 |
| Revenue Growth | ★ 13.05 | 9.55 |
| 52 Week Low | $50.82 | $20.48 |
| 52 Week High | $85.84 | $29.01 |
| Indicator | RDNT | GNTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.77 | 37.97 |
| Support Level | $69.96 | $21.26 |
| Resistance Level | $78.57 | $22.26 |
| Average True Range (ATR) | 2.55 | 0.44 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 65.79 | 17.55 |
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion, with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.